Objective To report the 5-year risk and to identify risk factors for the development of a seminal acute or progressive clinical event in a multi-national cohort of asymptomatic subjects meeting 2009 RIS Criteria. Methods Retrospectively identified RIS subjects from 22 databases within 5 countries were evaluated. Time to the first clinical event related to demyelination (acute or 12-month progression of neurological deficits) was compared across different groups by univariate and multivariate analyses utilizing a Cox regression model. Results Data were available in 451 RIS subjects (F: 354 (78.5%)). The mean age at from the time of the first brain MRI revealing anomalies suggestive of MS was 37.2 years (y) (median: 37.1 y, range: 11–74 y) with mean clinical follow-up time of 4.4 y (median: 2.8 y, range: 0.01–21.1 y). Clinical events were identified in 34% (standard error = 3%) of individuals within a 5-year period from the first brain MRI study. Of those who developed symptoms, 9.6% fulfilled criteria for primary progressive MS. In the multivariate model, age [hazard ratio (HR): 0.98 (95% CI: 0.96–0.99); p = 0.03], sex (male) [HR: 1.93 (1.24–2.99); p = 0.004], and lesions within the cervical or thoracic spinal cord [HR: 3.08 (2.06–4.62); p = <0.001] were identified as significant predictors for the development of a first clinical event. Interpretation These data provide supportive evidence that a meaningful number of RIS subjects evolve to a first clinical symptom. An age <37 y, male sex, and spinal cord involvement appear to be the most important independent predictors of symptom onset.
References
[1]
Okuda DT, Mowry EM, Beheshtian A, Waubant E, Baranzini SE, et al. (2009) Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome. Neurology 72: 800–805. doi: 10.1212/01.wnl.0000335764.14513.1a
[2]
Lebrun C, Bensa C, Debouverie M, De Seze J, Wiertlievski S, et al. (2008) Unexpected multiple sclerosis: follow-up of 30 patients with magnetic resonance imaging and clinical conversion profile. J Neurol Neurosurg Psychiatry 79: 195–198. doi: 10.1136/jnnp.2006.108274
[3]
Siva A, Saip S, Altintas A, Jacob A, Keegan BM, et al. (2009) Multiple sclerosis risk in radiologically uncovered asymptomatic possible inflammatory-demyelinating disease. Mult Scler 15: 918–927. doi: 10.1177/1352458509106214
[4]
Lebrun C, Blanc F, Brassat D, Zephir H, de Seze J, et al. (2010) Cognitive function in radiologically isolated syndrome. Mult Scler 16: 919–925. doi: 10.1177/1352458510375707
[5]
De Stefano N, Stromillo ML, Rossi F, Battaglini M, Giorgio A, et al. (2011) Improving the characterization of radiologically isolated syndrome suggestive of multiple sclerosis. PLoS One 6: e19452. doi: 10.1371/journal.pone.0019452
[6]
Gabelic T, Radmilovic M, Posavec V, Skvorc A, Boskovic M, et al.. (2012) Differences in oligoclonal bands and visual evoked potentials in patients with radiologically and clinically isolated syndrome. Acta Neurol Belg.
[7]
Giorgio A, Stromillo ML, Rossi F, Battaglini M, Hakiki B, et al. (2011) Cortical lesions in radiologically isolated syndrome. Neurology 77: 1896–1899. doi: 10.1212/wnl.0b013e318238ee9b
[8]
Gabelic T, Ramasamy DP, Weinstock-Guttman B, Hagemeier J, Kennedy C, et al.. (2013) Prevalence of Radiologically Isolated Syndrome and White Matter Signal Abnormalities in Healthy Relatives of Multiple Sclerosis Patients. AJNR Am J Neuroradiol.
[9]
Stromillo ML, Giorgio A., Rossi F., Battaglini M., Hakiki B., Malentacchi G., Santangelo M., Gasperini C., Bartolozzi M.L., Portaccio E., Amato M.P., De Stefano, N. (2013) Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome. Neurology.
[10]
Lebrun C, Bensa C, Debouverie M, Wiertlevski S, Brassat D, et al. (2009) Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patients. Arch Neurol 66: 841–846. doi: 10.1001/archneurol.2009.119
[11]
Lebrun C, Le Page E, Kantarci O, Siva A, Pelletier D, et al. (2012) Impact of pregnancy on conversion to clinically isolated syndrome in a radiologically isolated syndrome cohort. Mult Scler 18: 1297–1302. doi: 10.1177/1352458511435931
Kruit MC, van Buchem MA, Launer LJ, Terwindt GM, Ferrari MD (2010) Migraine is associated with an increased risk of deep white matter lesions, subclinical posterior circulation infarcts and brain iron accumulation: the population-based MRI CAMERA study. Cephalalgia 30: 129–136. doi: 10.1111/j.1468-2982.2009.01904.x
[14]
Liu S, Kullnat J, Bourdette D, Simon J, Kraemer DF, et al. (2013) Prevalence of brain magnetic resonance imaging meeting Barkhof and McDonald criteria for dissemination in space among headache patients. Mult Scler 19: 1101–1105. doi: 10.1177/1352458512471874
[15]
Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, et al. (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69: 292–302. doi: 10.1002/ana.22366
[16]
Vernooij MW, Ikram MA, Tanghe HL, Vincent AJ, Hofman A, et al. (2007) Incidental findings on brain MRI in the general population. N Engl J Med 357: 1821–1828. doi: 10.1056/nejmoa070972
[17]
Koch-Henriksen N, Sorensen PS (2010) The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol 9: 520–532. doi: 10.1016/s1474-4422(10)70064-8
[18]
Scalfari A, Neuhaus A, Daumer M, Ebers GC, Muraro PA (2011) Age and disability accumulation in multiple sclerosis. Neurology 77: 1246–1252. doi: 10.1212/wnl.0b013e318230a17d
[19]
Confavreux C, Vukusic S, Adeleine P (2003) Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 126: 770–782. doi: 10.1093/brain/awg081
[20]
Tutuncu M, Tang J, Zeid NA, Kale N, Crusan DJ, et al. (2013) Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis. Mult Scler 19: 188–198. doi: 10.1177/1352458512451510
[21]
Cohen AB, Neema M, Arora A, Dell'oglio E, Benedict RH, et al. (2012) The relationships among MRI-defined spinal cord involvement, brain involvement, and disability in multiple sclerosis. J Neuroimaging 22: 122–128. doi: 10.1111/j.1552-6569.2011.00589.x
[22]
Oh J, Saidha S, Chen M, Smith SA, Prince J, et al.. (2013) Spinal cord quantitative MRI discriminates between disability levels in multiple sclerosis. Neurology.
[23]
Bot JC, Barkhof F, Lycklama a Nijeholt G, van Schaardenburg D, Voskuyl AE, et al. (2002) Differentiation of multiple sclerosis from other inflammatory disorders and cerebrovascular disease: value of spinal MR imaging. Radiology 223: 46–56. doi: 10.1148/radiol.2231010707
[24]
Sombekke MH, Wattjes MP, Balk LJ, Nielsen JM, Vrenken H, et al. (2013) Spinal cord lesions in patients with clinically isolated syndrome: A powerful tool in diagnosis and prognosis. Neurology 80: 69–75. doi: 10.1212/wnl.0b013e31827b1a67
[25]
Tintore M, Rovira A, Arrambide G, Mitjana R, Rio J, et al. (2010) Brainstem lesions in clinically isolated syndromes. Neurology 75: 1933–1938. doi: 10.1212/wnl.0b013e3181feb26f
[26]
Jacobs LD, Beck RW, Simon JH, Kinkel RP, Brownscheidle CM, et al. (2000) Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. N Engl J Med 343: 898–904. doi: 10.1016/s0002-9394(00)00915-6
[27]
Comi G, Martinelli V, Rodegher M, Moiola L, Bajenaru O, et al. (2009) Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial. Lancet 374: 1503–1511. doi: 10.1016/s0140-6736(09)61259-9
[28]
Kappos L, Polman CH, Freedman MS, Edan G, Hartung HP, et al. (2006) Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes. Neurology 67: 1242–1249. doi: 10.1212/01.wnl.0000237641.33768.8d
[29]
McDonnell GV, Cabrera-Gomez J, Calne DB, Li DK, Oger J (2003) Clinical presentation of primary progressive multiple sclerosis 10 years after the incidental finding of typical magnetic resonance imaging brain lesions: the subclinical stage of primary progressive multiple sclerosis may last 10 years. Mult Scler 9: 204–209. doi: 10.1191/1352458503ms890cr
